Exploring the Effect of GLP-1 Agonists on Multiple Sclerosis Disease Progression (P11-1.007)

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000211085
Citations
2
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
2.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring the Effect of GLP-1 Agonists on Multiple Sclerosis Disease Progression (P11-1.007)

Aparna Manoj, Kamran Ali, Abdirahman M. Ali, Elizabeth H. Morrison-Banks
2 citations
Neurology
Diabetes Treatment and Management
2.59
article

Exploring the Effect of GLP-1 Agonists on Multiple Sclerosis Disease Progression (P11-1.007)

Aparna Manoj, Kamran Ali, Abdirahman M. Ali, Elizabeth H. Morrison-Banks
article en
2 citations

Abstract

No abstract available for this paper.
NeurologyVol. 104(7_Supplement_1)
University of California, Riverside (US)
Good health and well-being
Openalex Percentile: Top 11%
Diabetes Treatment and Management
2.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Exploring the Effect of GLP-1 Agonists on Multiple Sclerosis Disease Progression (P11-1.007) — Aparna Manoj, Kamran Ali, et al. · Neurology (2025) | TGRS Research Map | TGRS